Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.